Davidson Michael H. 4
4 · BioAge Labs, Inc. · Filed Sep 27, 2024
Insider Transaction Report
Form 4
Davidson Michael H.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-25+15,000→ 15,000 totalExercise: $18.00Exp: 2034-09-24→ Common Stock (15,000 underlying) - Award
Stock Option (Right to Buy)
2024-03-26+33,986→ 33,986 totalExercise: $8.39Exp: 2034-03-25→ Common Stock (33,986 underlying)
Footnotes (3)
- [F1]The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.
- [F2]This option award represents an equity security previously reported on the reporting person's Form 3, which was acquired through an exempt transaction with the Issuer prior to the Issuer registering a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended. It is reported herein as a transaction pursuant to Rule 16a-2(a).
- [F3]The option vested or vests as to 1/36th of the total award monthly, with the first tranche vesting on April 26, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.